BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17306361)

  • 1. Anti-angiogenic gene therapy of cancer: current status and future prospects.
    Persano L; Crescenzi M; Indraccolo S
    Mol Aspects Med; 2007 Feb; 28(1):87-114. PubMed ID: 17306361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic gene therapy for cancer (review).
    Isayeva T; Kumar S; Ponnazhagan S
    Int J Oncol; 2004 Aug; 25(2):335-43. PubMed ID: 15254730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic strategies for cancer therapy (Review).
    Benouchan M; Colombo BM
    Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy.
    Billy F; Ribba B; Saut O; Morre-Trouilhet H; Colin T; Bresch D; Boissel JP; Grenier E; Flandrois JP
    J Theor Biol; 2009 Oct; 260(4):545-62. PubMed ID: 19615383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dormant tumors and organs resistant to metastasis after gene transfer: dream and reality of anti-angiogenic gene therapy].
    Li H; Dkhissi F; Grenet C; Soria C; Lu H
    Therapie; 2001; 56(5):501-10. PubMed ID: 11806286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undermining tumor angiogenesis by gene therapy: an emerging field.
    Indraccolo S
    Curr Gene Ther; 2004 Sep; 4(3):297-308. PubMed ID: 15384943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis meets immunology: cytokine gene therapy of cancer.
    Minuzzo S; Moserle L; Indraccolo S; Amadori A
    Mol Aspects Med; 2007 Feb; 28(1):59-86. PubMed ID: 17306360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of anti-angiogenic therapy and virotherapy: arming oncolytic viruses with anti-angiogenic genes.
    Tysome JR; Lemoine NR; Wang Y
    Curr Opin Mol Ther; 2009 Dec; 11(6):664-9. PubMed ID: 20072943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis: biology and therapeutic prospects.
    Harris SR; Thorgeirsson UP
    In Vivo; 1998; 12(6):563-70. PubMed ID: 9891218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potentials of angiostatin in the treatment of cancer.
    Cao Y
    Haematologica; 1999 Jul; 84(7):643-50. PubMed ID: 10406908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis research: from laboratory to clinic.
    Folkman J
    Forum (Genova); 1999; 9(3 Suppl 3):59-62. PubMed ID: 10607848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous angiogenesis inhibitors.
    Folkman J
    APMIS; 2004; 112(7-8):496-507. PubMed ID: 15563312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis.
    Jung YD; Ahmad SA; Liu W; Reinmuth N; Parikh A; Stoeltzing O; Fan F; Ellis LM
    Semin Cancer Biol; 2002 Apr; 12(2):105-12. PubMed ID: 12027582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.